Feasibility of outpatient administration of ciltacabtagene autoleucel and reduction in healthcare utilization cost: the Vanderbilt experienceIhunayachi Ohuabunwa, Olalekan O. Oluwole, Phavina A Akhom et al.|Bone Marrow Transplantation|2025Cited by 0
Feasibility of Outpatient Administration of Ciltacabtagene Autoleucel for the Treatment of Relapsed Refractory Multiple Myeloma: The Vanderbilt ExperienceMegan Wanca, Eden Biltibo, Grace Johnson Mercadante et al.|Transplantation and Cellular Therapy|2026Cited by 0